PCI Biotech: Presentation of fimaChem for bile duct cancer at IPA masterclass series

by NASDAQ Market News November 8, 2021

NASDAQ Market News
Click here to email author

CytoDyn Submits Breakthrough Therapy Designation Application to FDA for Leronlimab as a Treatment for Metastatic Triple-Negative Breast Cancer (mTNBC); Fast Track Designation for mTNBC was received previously

iOnctura Clinical Expansion Positions Lead PI3Kδ Inhibitor IOA-244 for Potential Registration Studies in Metastatic Uveal Melanoma

Ads